NBCNBC News·3hHealth
score-0.45
FDA Advisory Panel Moves to Expand Patient Access to Peptide Treatments, Despite Internal Scientific Debate
Original
FDA panel recommends easing restrictions on several peptides
“Negative framing emphasizes 'narrowly voted' disagreement and 'strong objections' from scientists, implying regulatory capture and safety concerns.”